Definitive Healthcare Corp. (DH)
| Market Cap | 138.60M -57.8% |
| Revenue (ttm) | 241.52M -4.2% |
| Net Income | -138.93M |
| EPS | -1.30 |
| Shares Out | 142.81M |
| PE Ratio | n/a |
| Forward PE | 5.81 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 262,592 |
| Open | 1.0600 |
| Previous Close | 1.0400 |
| Day's Range | 0.9301 - 1.0600 |
| 52-Week Range | 0.9301 - 4.7000 |
| Beta | 1.60 |
| Analysts | Hold |
| Price Target | 3.08 (+217.36%) |
| Earnings Date | May 7, 2026 |
About DH
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician... [Read more]
Financial Performance
In 2025, Definitive Healthcare's revenue was $241.52 million, a decrease of -4.24% compared to the previous year's $252.20 million. Losses were -$138.93 million, -66.37% less than in 2024.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for DH stock is "Hold." The 12-month stock price target is $3.08, which is an increase of 217.36% from the latest price.
News
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025
FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, to...
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced tha...
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference
FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, C...
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025
FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, toda...
Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum
New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an i...
Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that...
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025
FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, toda...
Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of...
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025
FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today...
Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that...
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, toda...
Definitive Healthcare to Present at the Raymond James 2025 Institutional Investors Conference
FRAMINGHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare named a 2025 Best Places to Work in Boston by Built In
FRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of Built I...
Definitive Healthcare to Present at the 27th Annual Needham Growth Conference
FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase ...
Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations
Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement Monocl Conferences equips life science organizations with an intuitive...
Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions
Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities Market Forecast equips providers ...
Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
On September 30, 2024, Irenic Capital Management LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 6,413,185 shares of Definitive Healthcare Corp (DH, Financi...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Definitive Health...
Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) on behalf of investors ...